Abstract:Objective To establish an immortalized human hepatocyte cell line (IHCL) and evaluate the feasibility of producing artificial liver cells by using the cell line. Methods Primary human hepatocytes were transfected with simian virus 40 large tumor (SV40T) antigen and human telomerase reverse transcriptase (hTERT) to establish IHCL. The proliferation curve of IHCL was analyzed by MTT assay, and the cell cycle was analyzed by flow cytometry. The IHCL was inoculated locally at the skin and liver of nude mice to evaluate the tumorigenesis of the cells. The mRNA expression of hepatocyte-specific genes was detected by RT-PCR, and the expressions of the proteins associated with liver function were determined by Western blotting. The IHCL was cultured on microcarriers, Cytodex 3, and the proliferation and density of the cells were analyzed. The IHCL was co-cultured with sera from 5 patients with severe liver failure, the serum levels of bilirubin and urea nitrogen were determined to evaluate the therapeutic effect of IHCL.Results The established IHCL maintained the morphology of primary hepatocyte with a high proliferative ability and has been passaged for more than 80 times. The IHCL was diploid, and the doubling time was 38 hours. No tumorigenesis was found at the inoculation site in the nude mice. RT-PCR and Western blotting showed the expression of mRNA and protein of α1-antitrypsin, UDP-glucuronosyltransferase, glutamine synthetase, and glutathione-S-transferase in the IHCL. The IHCL grew well attaching to microcarrier, reaching a cell density of 2.86 × 106/ml. After being co-cultured with the sera obtained from patients with liver failure for 12 h, 24 h and 48 h, the concentration of total bilirubin in the sera decreased from (346 ± 94) μmol/L to (330 ± 97) μmol/L, (315 ± 97) μmol/L, and (295 ± 100) μmol/L respectively, and the concentration of direct bilirubin from (243 ± 70) μmol/L to (218 ± 76) μmol/L, (198 ± 79) μmol/L, and (184 ± 75) μmol/L, the differences between the base line and the measurements detected at the 24 h or 48 h were significant (P 0.05); meanwhile the level of blood urea nitrogen increased from (6.6 ± 0.9) μmol/L to (9.0 ± 0.9) μmol/L, (9.9 ± 1.1) μmol/L, and (12.5 ± 1.6) μmol/L, the differences between the base line and the measurements detected at the three time points were significant (P 0.01). Conclusions The established IHCL maintains the major biological characteristics and functions of primary human hepatocyte. It is feasible to produce artificial liver cells by using the cell line.

Establishment and characterization of immortalized human hepatocyte cell line for applications in bioartificial livers

Establishment and Characterization of an Immortalized Human Hepatic Stellate Cell Line for Applications in Co-Culturing with Immortalized Human Hepatocytes

Establishment Of Highly Differentiated Immortalized Human Hepatocyte Line With Simian Virus 40 Large Tumor Antigen For Liver Based Cell Therapy

Establishment of a Hepatocyte Line from Human with SV40LT Antigen

Establishment and further identification of immortalization human hepatocyte lines

Establishment and Characterization of Immortalized Porcine Hepatocytes for the Study of Hepatocyte Xenotransplantation.

Immortalization of porcine hepatocyte lines by transfection with simian virus 40 large T antigen and human telomerase reverse transcriptase

Establishment and Biological Characteristics of Immortalized Human Hepatocyte Cell Line

Establishment and Biological Study of Immortalized Human Hepatocyte Cell Line

Immortalization of liver cells: experimental studies and application

Reversibly immortalized hepatic progenitor cell line containing double suicide genes

Efficient Generation of Functional Hepatocyte-Like Cells from Mouse Liver Progenitor Cells Via Indirect Co-Culture with Immortalized Human Hepatic Stellate Cells.

Functional characteristics of reversibly immortalized hepatic progenitor cells derived from mouse embryonic liver.

Establishment and characterization of immortalized porcine neonatal hepatocytes without the use of viral components

Establishment and Characterization of an Immortalized Rat Hepatic Stellate Cell Line

Advances in cell sources of hepatocytes for bioartificial liver.

Transplantation of Immortalized Human Fetal Hepatocytes Prevents Acute Liver Failure in 90% Hepatectomized Mice.

Effects of Plasma from Patients with Acute on Chronic Liver Failure on Function of Cytochrome P450 in Immortalized Human Hepatocytes.

Porcine Hepatocyte Isolation and Reversible Immortalization Mediated by Retroviral Transfer and Site-Specific Recombination

Experimental study of bioartificial liver with cultured human liver cells.

Hepatoprotective effect of an immortal human fetal hepatic cell transplantation on CCL(4)-induced acute liver injury in mice.